<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 75-year-old man suffering from severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> was treated first with <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi>, then with steroid pulse therapy, and subsequently with metenolone <z:chebi fb="49" ids="30089,47622">acetate</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Marked elevation of transaminases was detected following initiation of treatment with metenolone <z:chebi fb="49" ids="30089,47622">acetate</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>This was followed by <z:hpo ids='HP_0001399'>hepatic failure</z:hpo> and <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Histopathological findings in autopsy specimens were compatible with the diagnosis of drug-induced liver impairment, for which metenolone <z:chebi fb="49" ids="30089,47622">acetate</z:chebi> was considered the most likely causative agent </plain></SENT>
<SENT sid="4" pm="."><plain>Liver impairment as a side effect of the use of this drug has been thought to be mild, reversible and rather infrequent </plain></SENT>
<SENT sid="5" pm="."><plain>However, as demonstrated in the case described here, it is apparent that extreme caution should be exercised when using this drug in debilitated patients </plain></SENT>
</text></document>